About US
Contact us
-
Pfizer's blockbuster rare disease med Vyndaqel hits supply snag in Korea thanks to quality problem: reportFollowing recent recalls of blood pressure medicines in North America, Pfizer has run into another drug manufacturing problem—this time in Asia. Pfizer halted the supply of rare disease med Vyn2022/7/13
-
Enhertu's standing ovation; Tessa's $126M CAR-T financing; Samsung's manufacturing dealAstraZeneca and Daiichi Sankyo's Enhertulooked on track to open a new breast cancer category: HER2-low. Singapore's Tessa Therapeutics grabbed $126 million in a series A to advance its CAR-T programs2022/7/11
-
Sanofi union members set strike date in Korea as wage negotiations stall: reportFed up with a low salary increase, unionized Sanofi workers in South Korea have threatened to go on strike. The workers will strike next month after failing to reach an agreement on a new wage2022/7/11
-
Novartis, staring down tough market for M&A, leans toward $25B Sandoz spinoff: BloombergFor months, the industry has waited patiently as Novartis mulls the fate of its $25 billion generics arm. Now, it appears a spinoff could be in the cards. Staring down a tough market for a pote2022/7/5
-
Astellas' gene therapy setback and new partnerships; Fujifilm's $1.6B expansionAstellaswas hit with another gene therapy clinical hold, but the Japanese pharma signed two partnerships focused on novel antibody-drug conjugate technology and undruggable targets. Fujifilm is pouri2022/7/5
-
J&J, Legend's new CAR-T data; Junshi's antiviral tops Pfizer's Paxlovid; Vir, WuXi end COVID pactJohnson & Johnson and Legend Biotech further padded the case for their BCMA CAR-T therapy Carvyktiin multiple myeloma. Junshi Biosciences said a China phase 3 trial has found its oral COVID antiv2022/6/30
-
Samsung Biologics ties up with Novartis in $81M contract manufacturing dealSamsung Biologics has signed an initial $81 million contract manufacturing and development deal with Novartis, marking the first time the two companies have worked together. Samsung Biologicsre2022/6/30
-
Sanofi union members set strike date in Korea as wage negotiations stall: reportFed up with a low salary increase, unionized Sanofi workers in South Korea have threatened to go on strike. The workers will strike next month after failing to reach an agreement on a new wage2022/6/28
-
Enhertu's standing ovation; Tessa's $126M CAR-T financing; Samsung's manufacturing dealAstraZeneca and Daiichi Sankyo's Enhertulooked on track to open a new breast cancer category: HER2-low. Singapore's Tessa Therapeutics grabbed $126 million in a series A to advance its CAR-T programs2022/6/28
-
Game on, Pfizer: Merck's Vaxneuvance boosts pneumococcal vaccine fight with coveted pediatric nodThis spring, when the FDA pushed its target date for pediatric approval of Merck’s pneumococcal vaccine Vaxneuvance back by 90 days, it was a blow to the company’s hope to get its next-generation sho2022/6/23